REGENXBIO Shares Promising Details from Q1 2026 Financial Report and Research Progress#United_States#Rockville#REGENXBIO#RGX-202#Phase_III
REGENXBIO Shares Promising Details from Q1 2026 Financial Report and Research Progress
In a recent update, REGENXBIO highlighted its Q1 2026 performance, revealing major milestones in gene therapy development, particularly RGX-202.
third-news.com
May 14, 2026 at 11:21 AM
REGENXBIO Shares Promising Details from Q1 2026 Financial Report and Research Progress#United_States#Rockville#REGENXBIO#RGX-202#Phase_III